mGluR4 Protein

mGluR4 Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">mGluR4 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Description</td>
</tr>
<tr>
<td class="label">N-terminal VFT domain</td>
<td>Large extracellular domain (~400 aa) with ligand binding site</td>
</tr>
<tr>
<td class="label">Cysteine-rich domain</td>
<td>Linker between VFT and 7TM</td>
</tr>
<tr>
<td class="label">7 Transmembrane domain</td>
<td>Classic seven-helix bundle (TM1-TM7)</td>
</tr>
<tr>
<td class="label">C-terminal tail</td>
<td>Intracellular domain with phosphorylation sites</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebellum (Purkinje cells)</td>
<td>Very high</td>
</tr>
<tr>
<td class="label">Striatum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>Low-moderate</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">LSP4-2022</td>
<td>mGluR4 agonist</td>
</tr>
<tr>
<td class="label">PHCCC</td>
<td>mGluR4 PAM</td>
</tr>
<tr>
<td class="label">VU0155041</td>
<td>mGluR4 PAM</td>
</tr>
<tr>

mGluR4 Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">mGluR4 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Description</td>
</tr>
<tr>
<td class="label">N-terminal VFT domain</td>
<td>Large extracellular domain (~400 aa) with ligand binding site</td>
</tr>
<tr>
<td class="label">Cysteine-rich domain</td>
<td>Linker between VFT and 7TM</td>
</tr>
<tr>
<td class="label">7 Transmembrane domain</td>
<td>Classic seven-helix bundle (TM1-TM7)</td>
</tr>
<tr>
<td class="label">C-terminal tail</td>
<td>Intracellular domain with phosphorylation sites</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebellum (Purkinje cells)</td>
<td>Very high</td>
</tr>
<tr>
<td class="label">Striatum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>Low-moderate</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">LSP4-2022</td>
<td>mGluR4 agonist</td>
</tr>
<tr>
<td class="label">PHCCC</td>
<td>mGluR4 PAM</td>
</tr>
<tr>
<td class="label">VU0155041</td>
<td>mGluR4 PAM</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Selectivity</td>
</tr>
<tr>
<td class="label">VU0415370</td>
<td>mGluR4 PAM</td>
</tr>
<tr>
<td class="label">ADX88178</td>
<td>mGluR4 PAM</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">cAMP/PKA</td>
<td>Inhibited</td>
</tr>
<tr>
<td class="label">Ca²⁺ channels</td>
<td>Inhibited</td>
</tr>
<tr>
<td class="label">K⁺ channels</td>
<td>Activated</td>
</tr>
<tr>
<td class="label">ERK/MAPK</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">PI3K/Akt</td>
<td>Enhanced</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

mGluR4 (Metabotropic Glutamate Receptor 4), encoded by the GRM4 gene (also known as GRM4 or mGlu4), is a member of the Group III metabotropic glutamate receptor family. Unlike Group I and II mGluRs, Group III receptors are primarily presynaptic inhibitory autoreceptors that suppress neurotransmitter release throughout the central nervous system. mGluR4 is highly expressed in the cerebellum, basal ganglia, and hippocampus, making it particularly relevant for motor control, learning, and neurodegenerative diseases [@petrovich2024].

The receptor has emerged as an attractive therapeutic target for Parkinson's disease, where mGluR4 activation can modulate basal ganglia circuitry to reduce motor symptoms. Additionally, mGluR4 modulation has shown promise in epilepsy, anxiety disorders, and neuroprotection. The receptor's presynaptic localization allows for fine-tuned modulation of synaptic transmission without directly affecting postsynaptic excitability.

Gene and Protein Structure

Gene Organization

The GRM4 gene (Gene ID: 2914) is located on chromosome 6p21.3 in humans. The gene spans approximately 35 kb and contains 9 exons. Alternative splicing produces multiple mRNA isoforms with distinct expression patterns. The GRM4 promoter contains regulatory elements responsive to neuronal activity and developmental cues.

Key features:

• Alternative splicing in the C-terminal tail
• Tissue-specific expression regulation
• Activity-dependent expression changes

Protein Architecture

mGluR4 is a class C GPCR with the characteristic architecture:

The ligand binding pocket has lower glutamate affinity than Group I/II receptors, requiring higher glutamate concentrations for activation. This allows mGluR4 to function as a high-threshold sensor of synaptic glutamate release.

Post-translational Modifications

• N-linked glycosylation in extracellular domains
• Disulfide bonds in the cysteine-rich domain
• Phosphorylation at serine/threonine residues
• Palmitoylation for membrane anchoring

Dimeric Structure

mGluR4 forms homodimers on the cell surface. The dimer interface involves both the VFT and transmembrane domains. Unlike Group II receptors, mGluR4 shows little heterodimerization with other mGluR subtypes.

Normal Function in the Nervous System

Presynaptic Inhibition

mGluR4 functions as an inhibitory presynaptic autoreceptor: [@rossi2022]

This feedback loop prevents excessive synaptic activity and maintains transmitter homeostasis.

Brain Region Distribution

Cerebellar Function

mGluR4 plays crucial roles in cerebellar circuitry: [@tattoli2023]

• Purkinje cell modulation: Inhibits excitatory input to Purkinje cells
• Motor learning: mGluR4 is required for certain forms of cerebellar learning
• Coordination: Modulates output from cerebellar nuclei

Basal Ganglia Modulation

mGluR4 significantly influences basal ganglia function: [@valenti2022]

• Striatal terminals: mGluR4 on striatocortical and striatonigral terminals
• Substantia nigra: Modulates dopaminergic neuron activity
• Motor output: Fine-tunes movement through indirect pathway

Role in Neurodegenerative Diseases

Parkinson's Disease

mGluR4 is a promising therapeutic target for PD: [@ishibashi2023]

Basal Ganglia Circuitry

• mGluR4 activation reduces excessive striatal output
• Normalizes indirect pathway activity
• Reduces motor symptoms in models

Neuroprotection

• mGluR4 agonists protect dopaminergic neurons: [@kim2024]
• Reduces excitotoxicity in substantia nigra
• Modulates neuroinflammation

Therapeutic Potential

mGluR4 modulators offer several advantages: [@conn2024]

• Non-dopaminergic approach to PD
• May reduce L-DOPA-induced dyskinesias
• Potential for disease modification

Alzheimer's Disease

mGluR4 involvement in AD: [@williams2024]

• Altered expression in AD brain regions
• Modulates hippocampal synaptic function
• Neuroprotective potential through reduced excitotoxicity

Epilepsy

mGluR4 is a key regulator of seizure activity: [@lerner2023]

• mGluR4 activation has anticonvulsant effects
• Modulates excitatory neurotransmission
• Potential for seizure prevention

Huntington's Disease

mGluR4 dysregulation in HD: [@anderson2023]

• Altered expression in striatum
• Contributes to excitotoxicity
• Therapeutic modulation shows promise

Cerebellar Ataxias

mGluR4 mutations are associated with cerebellar disorders

• Altered motor coordination
• Synaptic dysfunction in Purkinje cells

Therapeutic Targeting

Agonists

Positive Allosteric Modulators

mGluR4 PAMs enhance receptor function: [@davies2023]

Allosteric Considerations

• Subtype selectivity: Achieving selectivity vs. other Group III mGluRs
• BBB penetration: Critical for CNS indications
• Dose optimization: Balancing efficacy with side effects

Challenges

Signaling Pathways

mGluR4 couples to Gi/o proteins:

Intracellular Mechanisms

Related Pages

• [GRM4 Gene](/genes/grm4)
• [mGluR6 Protein](/proteins/mglur6-protein)
• [mGluR7 Protein](/proteins/mglur7-protein)
• [Glutamate Signaling](/mechanisms/glutamate-signaling)
• [Parkinson's Disease Mechanisms](/mechanisms/parkinsons-pathogenesis)
• [Cerebellar Function](/brain-regions/cerebellum)
• [Basal Ganglia](/brain-regions/basal-ganglia)
• [Synaptic Transmission](/mechanisms/synaptic-transmission)

External Links

• [UniProt: Q14833](https://www.uniprot.org/uniprot/Q14833)
• [IUPHAR: mGluR4](https://www.guidetopharmacology.org/GRAC/receptorDisplayForward?receptorId=420)
• [GeneCards: GRM4](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRM4)
• [OMIM: 604476](https://omim.org/entry/604476)

References